Alberto Matteelli - Infectious Diseases

Author Information

Alberto Matteelli is a prominent figure in the field of Infectious Diseases, specifically focusing on tuberculosis (TB) and related infections. He is affiliated with the University Department of Infectious and Tropical Diseases at the WHO Collaborating Centre for TB/HIV co-infection and TB elimination, located in the University of Brescia and Brescia Spedali Civili General Hospital, Brescia, Italy. His work significantly contributes to the understanding and management of infectious diseases on both a local and global scale.

Research Contributions

Alberto Matteelli has made substantial contributions to the field of infectious diseases, with a particular emphasis on tuberculosis and its interaction with other infections like HIV and COVID-19. His research addresses critical areas such as the diagnosis, treatment, and prevention of TB, as well as the impact of global health challenges like COVID-19 on TB presentation and outcomes. He has also explored the dynamics of TB infection among different population demographics, including native and foreign-born individuals, over extended periods. Additionally, his work extends to the evaluation of new diagnostic tests and preventive treatments for TB, alongside investigations into other infectious diseases like severe malaria in children.

Aliases

Alberto Matteelli is also known by several variations of his name, including A Matteelli and A. Matteelli. These aliases are used in various publications and citations within the academic community.

Publication and Citation Metrics

Metric	Value
Total Citation Count	10,201
H-Index	49
Paper Count	309

Publications:

When a Nontuberculous Mycobacterial Infection Reveals an Error of Immunity

DOI: 10.1097/INF.0000000000003461

Year: 2022

Clinical standards for the diagnosis, treatment and prevention of TB infection

DOI: 10.5588/ijtld.21.0753

Year: 2022

Mycobacterial skin infection

DOI: 10.1097/QCO.0000000000000820

Year: 2022

The role of IGRA in the diagnosis of tuberculosis infection, differentiating from active tuberculosis, and decision making for initiating treatment or preventive therapy of tuberculosis infection.

DOI: 10.1016/j.ijid.2022.02.047

Year: 2022

COVID-19 effect on TB presentation and outcome.

DOI: 10.5588/ijtld.22.0036

Year: 2022

Tuberculosis trend among native and foreign-born people over a 17 year period (2004–2020) in a large province in Northern Italy

DOI: 10.1038/s41598-021-02540-4

Year: 2021

Severe imported Plasmodium falciparum malaria in children: Characteristics and useful factors in the risk stratification.

DOI: 10.1016/j.tmaid.2021.102196

Year: 2021

Framework for the evaluation of new tests for tuberculosis infection

DOI: 10.1183/13993003.04078-2020

Year: 2021

TB preventive treatment in high- and intermediate-incidence countries: research needs for scale-up.

DOI: 10.5588/ijtld.21.0293

Year: 2021

Epidemiological and Clinical Characterization of Superinfections in Critically Ill Coronavirus Disease 2019 Patients

DOI: 10.1097/CCE.0000000000000430

Year: 2021

What is a Throat Swab?

How does ELISA work?

What is Herpes?

How Does the FDA Ensure the Safety of Antiviral Drugs?

How does Dengvaxia work?

What are condoms?

What Role Does Epidemiology Play in Outbreaks?

How Does the FDA Collaborate Internationally?

What are the Challenges in Ensuring Safety and Efficacy?

What are Adenoviruses?

Partnered Content Networks

Relevant Topics